The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review
Open accessAbstract
OBJECTIVE: To quantify efficacy and harm of pharmacological prevention of acute mountain sickness. DATA SOURCES: Systematic search (Medline, Embase, Cochrane Library, internet, bibliographies, authors) in any language, up to October 1999. STUDY SELECTION: Randomised placebo controlled trials. DATA EXTRACTION: Dichotomous data on efficacy and harm from 33 trials (523 subjects received 13 different interventions, 519 a placebo). DATA SYNTHESIS: At above 4000 m the mean incidence of acute mountain sickness with placebo was 67% (range 25% to 100%); incidence depended on the rate of ascent, but not on the altitude or the mode of ascent. Across all ascent rates, dexamethasone 8-16 mg prevented acute mountain sickness (relative risk 2.50 (95% confidence interval 1.71 to 3.66); number needed to treat (NNT) 2.8 (2.0 to 4.6)), without evidence of dose responsiveness. Acetazolamide 750 mg was also efficacious (2.18 (1.52 to 3.15); NNT 2.9 (2.0 to 5.2)), but 500 mg was not. In two trials, adverse reaction (including depression) occurred after dexamethasone was stopped abruptly (4.45 (1.08 to 18); NNT 3.7 (2.5 to 6.9)). With acetazolamide, paraesthesia (4.02 (1.71 to 9.43); NNT 3.0 (2.0 to 6.0)) and polyuria (4.24 (1.92 to 9.37); NNT 3.6 (2.5 to 6.2)) were reported. Data were sparse on nifedipine, frusemide (furosemide), dihydroxyaluminium-sodium, spironolactone, phenytoin, codeine, phenformin, antidiuretic hormone, and ginkgo biloba. CONCLUSIONS: At above 4000 m, with a high ascent rate, fewer than three subjects need to be treated with prophylactic dexamethasone 8-16 mg or acetazolamide 750 mg for one subject not to experience acute mountain sickness who would have done so had they all received a placebo. Acetazolamide 500 mg does not work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Cited by
Hackett, P. H., & Roach, R. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107123450206 · Cited by 1,302
Luks, A. M., Swenson, E. R., & Bärtsch, P. (2017) · European Respiratory Review · doi:10.1183/16000617.0096-2016 · Cited by 533
The Physiologic Basis of High-Altitude Diseases
West, J. B. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00010 · Cited by 365
Acute Mountain Sickness: Pathophysiology, Prevention, and Treatment
Imray, C., Wright, A., Subudhi, A., & Roach, R. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.02.003 · Cited by 318
The Practice of Travel Medicine: Guidelines by the Infectious Diseases Society of America
Hill, D. R., Ericsson, C. D., Pearson, R. D., Keystone, J. S., Freedman, D. O., Kozarsky, P. E., DuPont, H. L., Bia, F. J., Fischer, P. R., & Ryan, E. T. (2006) · Clinical Infectious Diseases · doi:10.1086/508782 · Cited by 296
Metadata
- Authors
- Dumont, L.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-07-29
- Volume
- 321
- Issue
- 7256
- Pages
- 267-272
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W2013426978
- Cited by
- 176
- References
- 2
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. https://app.cochat.ai/papers/10.1136/bmj.321.7256.267
- The paper
- Dumont, L. (2000). Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ. https://doi.org/10.1136/bmj.321.7256.267
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.